May Measurement Month 2017: an analysis of blood pressure screening results in Colombia-Americas.


Journal

European heart journal supplements : journal of the European Society of Cardiology
ISSN: 1520-765X
Titre abrégé: Eur Heart J Suppl
Pays: England
ID NLM: 100886647

Informations de publication

Date de publication:
Apr 2019
Historique:
accepted: 15 02 2019
entrez: 3 5 2019
pubmed: 3 5 2019
medline: 3 5 2019
Statut: ppublish

Résumé

Despite the availability of efficient methods to evaluate blood pressure (BP) and of safe and efficient medication to treat and control hypertension, the levels of awareness, treatment and control are very low globally, particularly in low- and middle-income countries. To highlight the importance of improving these rates, the International Society of Hypertension (ISH) endorsed by the World Hypertension League have implemented the May Measurement Month initiative. We present here the results obtained in Colombia. The Fundación Oftalmológica de Santander (FOSCAL) led the implementation of this strategy in Colombia and 11 departments participated. The data collection followed the guidelines of the ISH. The information collected was compiled for the report generation and the submission to the Technical Secretariat of the ISH. Data cleaning was performed locally by FOSCAL. Data were collated and analysed centrally. A total of 22 258 participants (58.8% female) were included in the analysis. Mean age was 40.9 ± 17.7 years. Age and sex-standardized BP excluding participants receiving BP medications was 118/74.3 mmHg, and in those on treatment 125/78 mmHg. High BP was present in 5036 (22.8%) individuals, 1637 of 18 644 (8.8%) who were not receiving anti-hypertensive medications were hypertensive, and 961 of 3359 (28.6%) receiving treatment were not controlled. These results highlight the need to develop innovative promotion strategies at individual and population levels to increase the awareness of the importance of BP, and the consequences of not having well-controlled hypertension. This initiative is an effective and easy to implement strategy that should be maintained in the coming years.

Identifiants

pubmed: 31043874
doi: 10.1093/eurheartj/suz087
pii: suz087
pmc: PMC6479493
doi:

Types de publication

Journal Article

Langues

eng

Pagination

D40-D43

Références

JAMA. 2013 Sep 4;310(9):959-68
pubmed: 24002282
J Hypertens. 2015 Jan;33(1):189-90
pubmed: 25470124
Circulation. 2016 Aug 9;134(6):441-50
pubmed: 27502908
J Hypertens. 2016 Dec;34(12):2344-2352
pubmed: 27662189
Lancet. 2016 Nov 26;388(10060):2665-2712
pubmed: 27671667
Lancet. 2017 Apr 29;389(10080):1678-1680
pubmed: 28463128
Lancet Glob Health. 2018 Jul;6(7):e736-e743
pubmed: 29778399

Auteurs

Patricio López-Jaramillo (P)

Dirección de Investigaciones, Fundación Oftalmológica de Santander (FOSCAL), Calle 155 A 23-04, El Bosque, Floridablanca, Santander, Colombia.
Instituto de Investigaciones Masira, Facultad de Salud, Universidad de Santander (UDES), Lagos del Cacique, Bucaramanga, Santander, Colombia.

Johanna Otero (J)

Dirección de Investigaciones, Fundación Oftalmológica de Santander (FOSCAL), Calle 155 A 23-04, El Bosque, Floridablanca, Santander, Colombia.
Instituto de Investigaciones Masira, Facultad de Salud, Universidad de Santander (UDES), Lagos del Cacique, Bucaramanga, Santander, Colombia.

Sandra Milena Rueda-Quijano (SM)

Dirección de Investigaciones, Fundación Oftalmológica de Santander (FOSCAL), Calle 155 A 23-04, El Bosque, Floridablanca, Santander, Colombia.

Paul Anthony Camacho (PA)

Dirección de Investigaciones, Fundación Oftalmológica de Santander (FOSCAL), Calle 155 A 23-04, El Bosque, Floridablanca, Santander, Colombia.
Escuela de Medicina, Facultad de Ciencias de la Salud, Universidad Autónoma de Bucaramanga (UNAB), Calle 155 A 23-17, El Bosque, Floridablanca, Santander, Colombia.

Juan José Rey (JJ)

Escuela de Medicina, Facultad de Ciencias de la Salud, Universidad Autónoma de Bucaramanga (UNAB), Calle 155 A 23-17, El Bosque, Floridablanca, Santander, Colombia.

Gregorio Sánchez (G)

Departamento de Medicina Interna, Facultad de Medicina, Universidad del Quindío, Hospital San Juan de Dios, Calle 17 Norte, Armenia, Quindio, Colombia.

Claudia Narváez (C)

Departamento de Epidemiología, Hospital Susana López de Valencia, Calle 15 # 17A-196, Popayán, Cauca, Colombia.

José Luis Accini (JL)

IPS Centro Científico Asistencial, Cra. 43b #80-101, Barranquilla, Atlantico, Colombia.
Unidad de cuidados críticos, Facultad de Medicina Universidad Libre and Universidad del Norte, Km. 7 Antigua Vía Puerto, Barranquilla, Atlántico, Colombia.

Edgar Arcos (E)

Unidad de estudios clínicos, Fundación Centro Médico COMETA, Cra. 39 19-94 Barrio PalermoPasto, Nariño, Colombia.

Henry García (H)

Departamento de Investigación Clínica, Fundación Centro de Investigaciones Biomédicas (RIESCARD), Cra. 5 #1870, El Espinal, Tolima, Colombia.

Maritza Pérez (M)

Departamento de Medicina Interna, Facultad de Medicina, Universidad Militar Nueva Granada, Trasversal 5 49-00, Bogota, Cundinamarca, Colombia.

Gustavo Aroca (G)

Facultad de Medicina, Universidad Simón Bolívar and Clínica de la Costa, Carrera 50 80-90, Barranquilla, Atlántico, Colombia.

Thomas Beaney (T)

Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London, WR12 7RH, UK.

Elsa Kobeissi (E)

Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London, WR12 7RH, UK.

Neil R Poulter (NR)

Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London, WR12 7RH, UK.

Classifications MeSH